Literature DB >> 15223654

Multiple myeloma in a patient with systemic lupus erythematosus, myasthenia gravis and non-familial diffuse palmoplantar keratoderma.

Halina Urbańska-Ryś1, Ewa Robak, RadzisŁaw Kordek, Jacek Bartkowiak, Piotr Rieske, Anna Woźniacka, Piotr Smolewski, Tadeusz Robak.   

Abstract

The coexistence of autoimmune diseases and malignancies including lymphoproliferative diseases is often reported in the literature. Here we report an unusual case with two autoimmune diseases--myasthenia gravis (MG) and systemic lupus erythematosus (SLE) associated with unique palmoplantar keratoderma (PK) which preceded the development of multiple myeloma (MM) for twenty and seven years respectively. MG associated with non-malignant thymoma developed in 1981 and was successfully treated with thymectomy and physostigmine. Thirteen years later SLE was diagnosed and until now it is also accompanied by skin lesions corresponding to non-familial, diffuse palmoplantar keratoderma which is resistant to treatment. In 2001 the patient revealed inguinal and abdominal lymphadenopathy first diagnosed as extramedullary plasmacytoma and then as multiple myeloma on the basis of bone marrow infiltration and monoclonal gammopathy. Therapy with VAD regimen achieved complete remission of the MM and significant improvement of the skin changes lasting for six months. We failed to collect sufficient numbers of CD 34+ cells for peripheral blood stem cell transplantation. Now the malignancy is in partial remission after CHOP therapy and the skin lesions have returned to their initial status. To our knowledge, this is the first case to be reported with coexistence of these four diseases. Copyright 2004 Taylor and Francis Ltd

Entities:  

Mesh:

Year:  2004        PMID: 15223654     DOI: 10.1080/10428190410001663581

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  7 in total

Review 1.  Early onset multiple myeloma in a patient with systemic lupus erythematosus: a case report and literature review.

Authors:  Jin Woo Choi; Seung Woo Han; Ki Tae Kwon; Gun Woo Kim
Journal:  Clin Rheumatol       Date:  2010-03-07       Impact factor: 2.980

Review 2.  Mixed connective tissue disease after thymectomy in refractory myasthenia gravis.

Authors:  Alexandra Kobza; Marissa Keenan; Catherine Ivory
Journal:  Rheumatol Int       Date:  2021-08-25       Impact factor: 3.580

3.  Non-lymphoma hematological malignancies in systemic lupus erythematosus.

Authors:  Mary Lu; Sasha Bernatsky; Rosalind Ramsey-Goldman; Michelle Petri; Susan Manzi; Murray B Urowitz; Dafna Gladman; Paul R Fortin; Ellen M Ginzler; Edward Yelin; Sang-Cheol Bae; Daniel J Wallace; Soren Jacobsen; Mary Anne Dooley; Christine A Peschken; Graciela S Alarcón; Ola Nived; Lena Gottesman; Lindsey A Criswell; Gunnar Sturfelt; Lene Dreyer; Jennifer L Lee; Ann E Clarke
Journal:  Oncology       Date:  2013-10-02       Impact factor: 2.935

4.  Palmoplantar keratoderma as a presenting sign of primary biliary cirrhosis.

Authors:  Kumar S Nadhan; Catherine Gupta Warner; Mary van den Berg-Wolf; Jesse M Civan; Shefali Ballal; Christina Lee Chung
Journal:  JAAD Case Rep       Date:  2017-12-18

5.  Systemic lupus Erythematosus and IgA multiple myeloma: a rare association?

Authors:  J Bila; N Suvajdzic; I Elezovic; M Colovic; D Boskovic
Journal:  Med Oncol       Date:  2007       Impact factor: 3.738

Review 6.  Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance.

Authors:  Alexei Shimanovsky; Juliana Alvarez Argote; Shruti Murali; Constantin A Dasanu
Journal:  BBA Clin       Date:  2016-05-25

7.  Myasthenia gravis with anti-muscle-specific tyrosine kinase antibodies during therapy for multiple myeloma: a case report.

Authors:  Shoko Sakano; Hirofumi Matsuyama; Hidehiro Ishikawa; Akihiro Shindo; Yuichiro Ii; Keita Matsuura; Minoru Mizutani; Norikazu Kawada; Hidekazu Tomimoto
Journal:  BMC Neurol       Date:  2020-06-12       Impact factor: 2.474

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.